In short
- Where: Beit HaRofim (the Doctors' House), 11 HaBarzel St., Building A, 7th floor, Unit 16A, Ramat HaHayal, Tel Aviv. Mainly for hair, and also for facial skin.
- What it is: made entirely from your own blood, with no anticoagulant in the preparation. After injection a fibrin mesh forms and releases growth factors gradually1.
- The evidence: encouraging but limited: one randomized trial in 74 women, and further small studies. There are no long-term follow-up data yet2.
- Diagnosis first: iPRF is not a substitute for finding out why the hair is falling out.
- Who treats you: at the clinic the treatment is performed by Dr. Dana Buchbut herself, a physician (M.D.).
What is iPRF, in plain words?
A liquid concentrate from your own blood, prepared without an anticoagulant and injected where you want to strengthen the tissue. Blood is drawn from a vein, as in a routine blood test, and spun in a centrifuge at a relatively low speed. The upper, liquid layer contains platelets, white blood cells and the clotting protein fibrinogen. After injection the fibrinogen turns into a fine fibrin mesh that holds the growth factors in place. The method started in dentistry and later moved to skin and hair1.
Without the anticoagulant used in PRP, a fibrin mesh forms, and it changes the rate at which growth factors are released. In a laboratory study, PRP released many growth factors in the first hour, while PRF concentrates released them steadily over ten days3. That study tested classic and advanced PRF, not liquid iPRF exactly, so it illustrates the principle rather than proving the release rate of the injected concentrate.
What is known about iPRF for hair, and what is not?
Early studies show improvement, and they are small. It is not yet known which protocol works best, how long the result lasts, or whether iPRF is truly better than PRP.
- Randomized comparative trial (2026): 74 women with female pattern hair loss received four sessions, four weeks apart, of PRP, iPRF or CGF. After 24 weeks hair counts rose in all groups, more with iPRF and CGF (about 26.5% and 27%) than with PRP (about 14.5%). Hair thickness did not differ, and the iPRF group had the lowest rate of side effects2.
- Study without a control group (2025): 30 patients with androgenetic alopecia who had not responded enough to standard treatments received six monthly injections. After six months 80% responded, with improved density and scalp symptoms4.
- Case series: 11 women received three sessions, and the number of follicles per area rose at 3 and 6 months5.
- Reviews: a 2024 systematic review found seven studies of iPRF in hair and face together, 130 patients in total, and called for more research6. A 2026 review of regenerative treatments reports improved density, alongside varied protocols and few long-term data7.
For comparison, PRP has many more trials, and a meta-analysis that compared PRP with minoxidil found no difference in hair density8. iPRF is a step behind PRP in the amount of research.
How is iPRF different from PRP and CGF?
All three come from your own blood; they differ in preparation and composition. PRP is prepared with an anticoagulant and releases most growth factors early. iPRF is prepared without an anticoagulant in a short, slow spin and forms a fibrin mesh. CGF is also prepared without an anticoagulant, with a programme of alternating spin speeds. In the only comparative trial in hair, iPRF and CGF achieved similar results, and both did better than PRP in hair count2. In practice the choice is made after diagnosis, according to the state of the follicles, not by the name of the treatment. More: PRP for hair in Tel Aviv.
Who may iPRF suit, and who less?
Mainly people with pattern hair loss at a stage where the follicles are still active, who prefer a treatment from their own blood with no foreign substance.
- Mild to moderate pattern hair loss, where the hair has thinned but not disappeared. The earlier you start, the more follicles there are to strengthen.
- People already on treatment, such as minoxidil or other medication, who want to add a layer. At the clinic most hair treatments are given as a combined protocol.
- People after a hair transplant who want to strengthen the natural hair around the transplanted area.
iPRF does not suit areas with no active follicles, an infection or active skin disease at the injection site, or a platelet or clotting disorder. In a completely bald area the solution is usually a transplant. In alopecia areata the treatments are different. Anaemia, deficiencies or thyroid problems can also cause hair loss, and are checked and treated first. We found no studies of iPRF in pregnancy or breastfeeding, so cosmetic treatment is usually not started then.
How is the treatment done, and how many sessions?
Much like PRP, with one practical difference: without an anticoagulant the liquid starts to gel, so it is injected shortly after preparation.
- A conversation and examination, including trichoscopy (a magnified examination of the scalp).
- Blood is drawn into special tubes with no anticoagulant.
- A short, slow spin in a centrifuge, and collection of the upper liquid layer.
- Injection into the scalp, or facial skin, with tiny injections. Pain relief is agreed before the treatment.
- Follow-up with standardized photos and magnified examination, to see in the data whether there is a change.
Most people return to routine the same day. In studies, a series of three to six sessions about a month apart was given, and the result was measured after 3 to 6 months. Hair grows in cycles, so the first sign is usually less shedding, and only later higher density. Your number of sessions depends on your condition and response, and there is no study of how many years the result lasts, so no duration is promised.
What are the side effects?
Mostly local and temporary: tenderness, redness, mild swelling and sometimes a small bruise at the injection site. The studies reviewed reported minimal or mild side effects26. Any injection carries a rare risk of infection, bleeding and local reaction, so choose a place with a clear procedure.
Dr. Dana Buchbut's clinic in Tel Aviv
Dr. Dana Buchbut has practised hair medicine for 16 years, and iPRF is one of the treatments she offers alongside PRP, CGF and other methods. Whether it suits you is decided after diagnosis, and it is usually part of a combined plan. She is a graduate of the Tel Aviv University Faculty of Medicine (M.D.) and holds an MBA from MIT, with clinical experience at Ichilov, Hadassah Ein Kerem and Brigham and Women's Hospital in the US. The clinic is wheelchair accessible.
Address: Beit HaRofim (the Doctors' House), 11 HaBarzel St., Building A, 7th floor, Unit 16A, Ramat HaHayal, Tel Aviv. No referral is needed. The consultation takes between 15 minutes and two hours, you receive an invoice that can be submitted to private health insurance, and if you go ahead with treatment the consultation fee is credited toward it. Consultations are in Hebrew or English. Book online or on WhatsApp at +972-54-556-8871. Directions: getting to the clinic in Ramat HaHayal.
Frequently asked questions
Where can I get iPRF hair treatment in Tel Aviv?
At Dr. Dana Buchbut's clinic in Ramat HaHayal, Tel Aviv, at Beit HaRofim, 11 HaBarzel St. Dr. Buchbut, M.D., has treated hair loss since 2010 and performs the iPRF treatment herself, after a trichoscopic scalp examination with a FotoFinder system. No referral is needed, and consultations are in Hebrew or English.
What is iPRF?
iPRF (injectable platelet-rich fibrin) is a liquid concentrate from your own blood, spun slowly with no anticoagulant or additives. The upper liquid layer, rich in platelets, white blood cells and fibrinogen, is injected into the scalp or skin, where it forms a fibrin mesh that releases growth factors gradually.
Is iPRF better than PRP?
In one randomized trial in women with pattern hair loss, hair counts rose more with iPRF than with PRP. That is encouraging but not final proof: one trial, women only, 24 weeks of follow-up. PRP has far more studies, so there is no clear-cut answer yet, and the choice depends on your condition.
Does iPRF work for men?
It is also used for men with pattern hair loss. The only randomized trial comparing the concentrates was done in women. In a study of 30 patients with androgenetic alopecia, without a control group, 80% responded after six months. For men the evidence is still limited.
Does iPRF hurt?
You feel small pricks and pressure, mainly on the scalp, and this can be eased. Pain relief is agreed before the treatment and can include cooling, numbing cream and laughing gas as needed.
How many iPRF sessions are needed, and when are results seen?
In studies, three to six sessions about a month apart were usually given, and the change was measured after 3 to 6 months. Your number of sessions depends on your condition and response, and no study has shown how long the result lasts.
Do I need a referral?
No. It is a private clinic, and you book directly online, on WhatsApp or by phone at +972-54-556-8871.
Sources
- Miron RJ, Gruber R, Farshidfar N, Sculean A, Zhang Y. Ten years of injectable platelet-rich fibrin. Periodontol 2000. 2024;94(1):92-113. PMID 38037213. doi.org
- Li M, Bai Y, Ye Z, et al. Comparative efficacy and safety of PRP, i-PRF and CGF for female pattern hair loss: a prospective multicenter randomized clinical trial. J Dermatolog Treat. 2026. PMID 42041234. doi.org
- Kobayashi E, Flückiger L, Fujioka-Kobayashi M, et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig. 2016;20(9):2353-2360. PMID 26809431. doi.org
- Yao S, Chen X, Li S, et al. New tool in our arsenal: efficacy of injectable platelet-rich fibrin (i-PRF) in androgenetic alopecia treatment. Arch Dermatol Res. 2025;317(1):493. PMID 40009221. doi.org
- Sharma S, Vhadra B, Quinlan DJ, et al. Injectable platelet-rich fibrin for treatment of female pattern hair loss. J Cosmet Laser Ther. 2024;26(1-4):17-25. PMID 38989555. doi.org
- Mohale SA, Thakare PV, Gaurkar SS, et al. Effectiveness of injectable platelet-rich fibrin therapy in alopecia and facial rejuvenation: a systematic review. Cureus. 2024;16(6):e62198. PMID 39011192. doi.org
- Behrangi E, Amiri S, Zeinali R, et al. A systematic review of clinical evidence on the efficacy and safety of conditioned media, platelet-rich fibrin, stromal vascular fraction, extracellular vesicles, and stem cells in androgenetic alopecia. Stem Cell Res Ther. 2026;17:194. PMID 41987228. doi.org
- Umar M, Anwar A, Shamim L, et al. Comparative efficacy and safety of platelet rich plasma (PRP) versus topical minoxidil for androgenetic alopecia: a systematic review and meta-analysis. Aesthetic Plast Surg. 2026. PMID 41219547. doi.org
Related reading
iPRF for hair
The method, the studies and the evidence in detail.
ReadPRP for hair in Tel Aviv
Who it suits, the treatment course and what to expect.
ReadHair loss doctor in Tel Aviv
How to choose a hair loss clinic in Israel.
ReadTrichoscopy (scalp analysis)
What the computerized scalp examination shows.
ReadThe information on this page is general and for education only. It does not replace an examination, diagnosis or personal medical advice. Any decision about treatment is made only after an examination.
